Impact of dexamethasone responsiveness on long-term outcome in patients with newly diagnosed myeloma

被引：0
|
作者：
Sinha, S. [1 ]
Rajkumar, S. V. [1 ]
Lacy, M. [1 ]
Hayman, S. [1 ]
Baudi, F. [1 ]
Dispenzieri, A. [1 ]
Lust, J. [1 ]
Greipp, P. [1 ]
Gertz, M. [1 ]
Kumar, S. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8603
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Long-term health-related quality of life in transplant-ineligible patients with newly diagnosed multiple myeloma receiving lenalidomide and dexamethasone
    Vogl, Dan T.
    Delforge, Michel
    Song, Kevin
    Guo, Shien
    Gibson, Craig J.
    Ervin-Haynese, Annette
    Facon, Thierry
    LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 398 - 405
  • [22] Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy
    Kourelis, Taxiarchis V.
    Kumar, Shaji K.
    Srivastava, Geetika
    Gertz, Morie A.
    Lacy, Martha Q.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Zeldenrust, Steven R.
    Leung, Nelson
    Kyle, Robert A.
    Russell, Stephen J.
    Dingli, David
    Lust, John A.
    Lin, Yi
    Kapoor, Prashant
    Go, Ronald
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (03) : 302 - 305
  • [23] Thalidomide plus dexamethasone for newly diagnosed myeloma
    Lindsey, H
    LANCET ONCOLOGY, 2002, 3 (12): : 711 - 711
  • [24] Vincristine, doxorubicin, and dexamethasone or thalidomide plus dexamethasone for newly diagnosed patients with multiple myeloma?
    Jimenez-Zepeda, Victor Hugo
    Dominguez-Martinez, Virginia Jeanet
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (03) : 239 - 244
  • [25] LONG-TERM OUTCOME OF 1,805 PEOPLE WITH NEWLY DIAGNOSED EPILEPSY
    Chen, Z.
    Brodie, M. J.
    Liew, D.
    Kwan, P.
    EPILEPSIA, 2015, 56 : 54 - 54
  • [26] Survival in Patients with Newly Diagnosed Myeloma Undergoing Therapy with Lenalidomide and Dexamethasone: Impact of High-Risk Cytogenetic Risk Status on Outcome
    Kapoor, Prasnant
    Kumar, Shaji
    Fonseca, Rafael
    Lacy, Martha Q.
    Wilzig, Thomas E.
    Hayman, Suzanne R.
    Dispenzieri, Angela
    Buadi, Francis
    Bergsagel, P. Leif
    Gertz, Morie
    Dalton, Robert
    Mikhael, Joseph
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russell, Stephen
    Roy, Vivek
    Zeldenrust, Steven R.
    Stewart, Keith
    Kyle, Robert A.
    Greipp, Philip R.
    Rajkumar, S. Vincent
    BLOOD, 2008, 112 (11) : 42 - 43
  • [27] Blood glucose at admission is a predictor of long-term outcome in patients with newly diagnosed heart disease.
    Cubero, J
    Martinez-Rubio, A
    Barahona, M
    Galla, G
    Perez, A
    DIABETOLOGIA, 2002, 45 : A381 - A381
  • [28] Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomas
    Nagy, Monika
    Schulz-Ertner, Daniela
    Bischof, Marc
    Welzel, Thomas
    Hof, Holger
    Debus, Juergen
    Combs, Stephanie E.
    TUMORI JOURNAL, 2009, 95 (03): : 317 - 324
  • [29] Favorable Long-Term Survival of Newly Diagnosed Multiple Myeloma Patients Using a Frontline Outpatient Tandem Approach
    Roy, Jean
    Ahmad, Imran
    LeBlanc, Richard
    Cohen, Sandra
    Lachance, Silvy
    Kiss, Thomas
    Sauvageau, Guy
    Roy, Denis-Claude
    Busque, Lambert
    Delisle, Jean-Sebastien
    Bambace, Nadia M.
    Bernard, Lea
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S353 - S354
  • [30] Long term results with tandem autotransplant for newly-diagnosed multiple myeloma patients
    Iacopino, Pasquale
    Irrera, Giuseppe
    Console, Giuseppe
    Messina, Giuseppe
    Pucci, Giulia
    Stelitano, Caterina
    Callea, Vincenzo
    Musolino, Caterina
    Iuliano, Franco
    Bruciatelli, Maura
    Piro, Eugenio
    Molica, Stefano
    Morabito, Fortunato
    Martino, Massimo
    ANNALS OF ONCOLOGY, 2005, 16 : 62 - 62
12345